• 19 December, 2024
Foreign Affairs, Geopolitics & National Security
MENU

U.S. Senate panel sets hearing on Russian gas pipeline amid Ukraine concerns

Thu, 23 Sep 2021   |  Reading Time: 2 minutes

WASHINGTON (Reuters) – The U.S. Senate Foreign Relations Committee scheduled a closed-door hearing on Sept. 29 to discuss Russia’s Nord Stream 2 natural gas pipeline, which several lawmakers say could harm allies in Eastern Europe.

Amos Hochstein, senior adviser for energy security at the U.S. Department of State, will testify, according to the committee’s website. Both European and U.S. lawmakers, including both Democrats and Republicans, opposed the $11 billion pipeline, which could allow Russia to double lucrative gas exports to Germany and other parts of Europe while bypassing and cutting off a source of income for political foe Ukraine.

Russia’s Gazprom said earlier this month it had finished construction of the pipeline, which would deliver gas from the Arctic via the Baltic Sea. The Biden administration has urged Germany to find ways to ensure Russia cannot use the pipeline to harm Ukraine or other allies in Eastern Europe.

The Biden administration concluded in May that Nord Stream 2 AG, the company behind the project, and its chief executive engaged in sanctionable behavior. But President Joe Biden waived the sanctions to allow time to work out a deal and continue rebuilding ties with Germany that were badly frayed during former President Donald Trump’s administration.

The president is under intense pressure from members of Congress to halt the waiver and impose the sanctions. Republican Senator Ted Cruz, a member of the foreign relations committee, is holding up many of Biden’s nominees for State Department posts until the sanctions are put in place.

 

(Reporting by Patricia Zengerle; Editing by Lisa Shumaker)

tagreuters.com2021binary_LYNXMPEH8M0NR-VIEWIMAGE



Chanakya Forum is now on . Click here to join our channel (@ChanakyaForum) and stay updated with the latest headlines and articles.

POST COMMENTS (0)

Leave a Comment

Featured Articles

Popular News